BECONASE

LOE Approaching

beclomethasone dipropionate

NDANASALAEROSOL, METERED
Approved
Sep 1981
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
10

Mechanism of Action

CLINICAL PHARMACOLOGY Mechanism of Action Following topical administration, beclomethasone dipropionate produces anti-inflammatory and vasoconstrictor effects. The mechanisms responsible for the anti-inflammatory action of beclomethasone dipropionate are unknown. Corticosteroids have been shown to…

Clinical Trials (5)

NCT02513160Phase 3Completed

Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma

Started Sep 2015
713 enrolled
Persistent Asthma
NCT02040779Phase 3Completed

A 12-week Safety and Efficacy Study of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Patients >=12 Years Old With Persistent Asthma

Started Dec 2013
273 enrolled
Persistent Asthma
NCT02030457Phase 1Completed

A Study to Investigate the Pharmacokinetics and Safety of Beclomethasone Dipropionate Administered by Breath-Actuated Inhaler and Metered-Dose Inhaler in Healthy Adults

Started Dec 2013
72 enrolled
Pharmacokinetics
NCT02031640Phase 3Completed

A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants >=12 Years Old With Persistent Asthma

Started Dec 2013
1,113 enrolled
Asthma
NCT02040766Phase 3Completed

A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants Ages 4-11 Years Old With Persistent Asthma

Started Dec 2013
628 enrolled
Asthma